ENST00000398226.8:c.*565G>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000398226.8(SELENOS):​c.*565G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0252 in 152,256 control chromosomes in the GnomAD database, including 86 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.025 ( 86 hom., cov: 32)
Exomes 𝑓: 0.13 ( 0 hom. )

Consequence

SELENOS
ENST00000398226.8 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.583

Publications

4 publications found
Variant links:
Genes affected
SELENOS (HGNC:30396): (selenoprotein S) This gene encodes a transmembrane protein that is localized in the endoplasmic reticulum (ER). It is involved in the degradation process of misfolded proteins in the ER, and may also have a role in inflammation control. This protein is a selenoprotein, containing the rare amino acid selenocysteine (Sec). Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Two additional phylogenetically conserved stem-loop structures (Stem-loop 1 and Stem-loop 2) in the 3' UTR of this mRNA have been shown to function as modulators of Sec insertion. An alternatively spliced transcript variant, lacking the SECIS element and encoding a non-Sec containing shorter isoform, has been described for this gene (PMID:23614019). [provided by RefSeq, Jul 2017]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000398226.8, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAdExome4 highest subpopulation (NFE) allele frequency = 0.167 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000398226.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SELENOS
NM_203472.3
c.*571G>C
3_prime_UTR
Exon 7 of 7NP_982298.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SELENOS
ENST00000398226.8
TSL:1
c.*565G>C
3_prime_UTR
Exon 7 of 7ENSP00000381282.3Q9BQE4

Frequencies

GnomAD3 genomes
AF:
0.0253
AC:
3845
AN:
152130
Hom.:
86
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00664
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0179
Gnomad ASJ
AF:
0.0297
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0440
Gnomad FIN
AF:
0.0277
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0384
Gnomad OTH
AF:
0.0259
GnomAD4 exome
AF:
0.125
AC:
1
AN:
8
Hom.:
0
Cov.:
0
AF XY:
0.167
AC XY:
1
AN XY:
6
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.167
AC:
1
AN:
6
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0252
AC:
3840
AN:
152248
Hom.:
86
Cov.:
32
AF XY:
0.0241
AC XY:
1791
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.00662
AC:
275
AN:
41534
American (AMR)
AF:
0.0178
AC:
273
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0297
AC:
103
AN:
3470
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5190
South Asian (SAS)
AF:
0.0436
AC:
210
AN:
4816
European-Finnish (FIN)
AF:
0.0277
AC:
294
AN:
10606
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0384
AC:
2614
AN:
68014
Other (OTH)
AF:
0.0251
AC:
53
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
193
385
578
770
963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0134
Hom.:
3
Bravo
AF:
0.0239

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.94
DANN
Benign
0.33
PhyloP100
-0.58
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs12438654;
hg19: chr15-101811293;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.